Some people who tried the heavily hyped, unregulated peptides now say they wish they hadn't. The Post collects their experiences.
Recap by typeshit. Full story at The Washington Post.
2:12
A short explainer on the experimental injection people call Reta, covering why it went viral and what is known so far about its safety.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
32:25
The channel walks through FDA inspection findings of mold at suppliers and what people taking GLP-1 medications should watch for.
A fresh warning points to more people ending up in hospital after taking peptides that aren't approved. Tap through for who issued it.
He says his blood work came in half a point from a diabetic result, which scared him into starting the drug. A personal account, not medical advice.
REX pitches the fund as covering developers, manufacturers and delivery platforms rather than just GLP-1 makers. It isn't open for purchase yet.
Loading…